Skip to main content
Elsevier

Advances in Immunology

  • 1st Edition, Volume 141 - March 21, 2019
  • Latest edition
  • Editor: Frederick W. Alt
  • Language: English

Advances in Immunology, Volume 141, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immun… Read more

Data Mining & ML

Unlock the cutting edge

Up to 20% on trusted resources. Build expertise with data mining, ML methods.

Explore now

Description

Advances in Immunology, Volume 141, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology. Articles address the wide range of topics that comprise immunology, with this volume focusing on recent advances in the cysteinyl leukotriene pathway and chromosome biology and immunology.

Key features

  • Presents current developments and comprehensive reviews in immunology
  • Provides the latest in a longstanding, respected serial on the subject matter
  • Focuses on recent advances in the cysteinyl leukotriene pathway and chromosome biology and immunology

Readership

Immunologists and infectious disease specialists, cell biologists and hematologists.

Table of contents

1. Multilayer regulation of CD4 T cell subset differentiation in the era of single cell genomics
Waradon Sungnak, Chao Wang and Vijay K. Kuchroo

2. Transcription factories in Igκ allelic choice and diversity
Sophiya Karki, Shiladitya Banerjee, Kaitlin Mclean, Aaron Dinner and Marcus R. Clark

3. Cis- and trans-factors affecting AID targeting and mutagenic outcomes in antibody diversification
Leng-Siew Yeap and Fei-Long Meng

4. Signaling control of antibody isotype switching
Zhangguo Chen and Jing H. Wang

Product details

  • Edition: 1
  • Latest edition
  • Volume: 141
  • Published: March 21, 2019
  • Language: English

About the editor

FA

Frederick W. Alt

Frederick W. Alt is a Howard Hughes Medical Institute (HHMI) Investigator and Director of the Program in Cellular and Molecular Medicine (PCMM) at Boston Children's Hospital (BCH). He is the Charles A. Janeway Professor of Pediatrics and Professor of Genetics at Harvard Medical School. He works on elucidating mechanisms that generate antigen receptor diversity and, more generally, on mechanisms that generate and suppress genomic instability in mammalian cells, with a focus on the immune and nervous systems. Recently, his group has developed senstive genome-wide approaches to identify mechanisms of DNA breaks and rearrangements in normal and cancer cells. He has been elected to the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, and the European Molecular Biology Organization. His awards include the Albert Szent-Gyorgyi Prize for Progress in Cancer Research, the Novartis Prize for Basic Immunology, the Lewis S. Rosensteil Prize for Distinugished work in Biomedical Sciences, the Paul Berg and Arthur Kornberg Lifetime Achievement Award in Biomedical Sciences, and the William Silan Lifetime Achievement Award in Mentoring from Harvard Medical School.
Affiliations and expertise
Investigator and Director, Program in Cellular and Molecular Medicine, Howard Hughes Medical Institute Research Laboratories, The Children's Hospital, Boston, MA, USA

View book on ScienceDirect

Read Advances in Immunology on ScienceDirect